A Study Looking at the Efficacy and Safety of PF-06823859 in Adults With Moderate to Severe Dermatomyositis
A Study Looking at the Efficacy and Safety of PF-06823859 in Adults With Moderate to Severe Dermatomyositis. A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of PF-06823859 in Adult Subjects With Dermatomyositis.
Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06823859
ClinicalTrials.gov Identifier (NCT): NCT03181893
Protocol ID: C0251002
PrintDownloadOpen Plain Language Summary Result: Click here